nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—Alprenolol—HTR1A—bipolar disorder	0.0157	0.429	CrCbGaD
Betaxolol—Pindolol—HTR1A—bipolar disorder	0.0135	0.369	CrCbGaD
Betaxolol—Propranolol—HTR1A—bipolar disorder	0.00736	0.201	CrCbGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00287	0.00298	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00281	0.00292	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00281	0.00292	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00277	0.00288	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00271	0.00282	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00268	0.00278	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00268	0.00278	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00262	0.00272	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00262	0.00272	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00259	0.00269	CbGpPWpGaD
Betaxolol—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00257	0.00267	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00254	0.00263	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00252	0.00261	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00246	0.00256	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00238	0.00247	CbGpPWpGaD
Betaxolol—ADRB1—G alpha (s) signalling events—POMC—bipolar disorder	0.00236	0.00245	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00235	0.00244	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00234	0.00243	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00233	0.00241	CbGpPWpGaD
Betaxolol—ADRB2—G alpha (s) signalling events—POMC—bipolar disorder	0.00231	0.0024	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.0023	0.00238	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.0023	0.00238	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.0023	0.00238	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00229	0.00238	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00225	0.00233	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00225	0.00233	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—ADM—bipolar disorder	0.00224	0.00233	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00222	0.00231	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—ADM—bipolar disorder	0.0022	0.00228	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—TACR1—bipolar disorder	0.00219	0.00227	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—TSHB—bipolar disorder	0.00219	0.00227	CbGpPWpGaD
Betaxolol—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00218	0.00226	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00217	0.00226	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00216	0.00224	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—TSHB—bipolar disorder	0.00214	0.00222	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—TACR1—bipolar disorder	0.00214	0.00222	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00211	0.00219	CbGpPWpGaD
Betaxolol—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00207	0.00214	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00201	0.00209	CbGpPWpGaD
Betaxolol—CYP1A2—Phase II conjugation—COMT—bipolar disorder	0.00199	0.00207	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00197	0.00204	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—DGKH—bipolar disorder	0.00192	0.00199	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—DGKH—bipolar disorder	0.00188	0.00195	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—HTR1A—bipolar disorder	0.00181	0.00188	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—TAC1—bipolar disorder	0.00178	0.00185	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—HTR1A—bipolar disorder	0.00177	0.00184	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—DRD5—bipolar disorder	0.00175	0.00182	CbGpPWpGaD
Betaxolol—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00175	0.00182	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—HTR2C—bipolar disorder	0.00175	0.00181	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—DRD1—bipolar disorder	0.00175	0.00181	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—TAC1—bipolar disorder	0.00174	0.00181	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—DGKH—bipolar disorder	0.00174	0.00181	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—RGS4—bipolar disorder	0.00172	0.00179	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—DRD5—bipolar disorder	0.00172	0.00178	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—DRD1—bipolar disorder	0.00171	0.00177	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—HTR2C—bipolar disorder	0.00171	0.00177	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—DGKH—bipolar disorder	0.0017	0.00177	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—DRD3—bipolar disorder	0.00169	0.00176	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—RGS4—bipolar disorder	0.00168	0.00175	CbGpPWpGaD
Betaxolol—CYP2D6—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.00167	0.00174	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—DRD3—bipolar disorder	0.00166	0.00172	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00164	0.00171	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—DRD4—bipolar disorder	0.00164	0.00171	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00161	0.00167	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—DRD4—bipolar disorder	0.00161	0.00167	CbGpPWpGaD
Betaxolol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—bipolar disorder	0.00161	0.00167	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—DRD5—bipolar disorder	0.00159	0.00165	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—RGS4—bipolar disorder	0.00156	0.00162	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—DRD5—bipolar disorder	0.00156	0.00162	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—DRD2—bipolar disorder	0.00153	0.00159	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—RGS4—bipolar disorder	0.00153	0.00159	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—DRD2—bipolar disorder	0.0015	0.00155	CbGpPWpGaD
Betaxolol—CYP1A2—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.00142	0.00147	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00141	0.00146	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00138	0.00143	CbGpPWpGaD
Betaxolol—CYP2D6—Biological oxidations—COMT—bipolar disorder	0.00138	0.00143	CbGpPWpGaD
Betaxolol—CYP2D6—Biological oxidations—MAOA—bipolar disorder	0.00137	0.00142	CbGpPWpGaD
Betaxolol—CYP2D6—Metapathway biotransformation—COMT—bipolar disorder	0.00136	0.00141	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—TRPC3—bipolar disorder	0.00133	0.00138	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—TRPC3—bipolar disorder	0.0013	0.00135	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—ADM—bipolar disorder	0.00127	0.00132	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.00125	0.00129	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—ADM—bipolar disorder	0.00124	0.00129	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—TSHB—bipolar disorder	0.00124	0.00128	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PDE4B—bipolar disorder	0.00124	0.00128	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—TACR1—bipolar disorder	0.00124	0.00128	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—TSHB—bipolar disorder	0.00121	0.00125	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PDE4B—bipolar disorder	0.00121	0.00125	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—TACR1—bipolar disorder	0.00121	0.00125	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—TRPC3—bipolar disorder	0.00121	0.00125	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—TRPC3—bipolar disorder	0.00118	0.00123	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—IMPA2—bipolar disorder	0.00118	0.00122	CbGpPWpGaD
Betaxolol—CYP1A2—Biological oxidations—COMT—bipolar disorder	0.00117	0.00121	CbGpPWpGaD
Betaxolol—CYP1A2—Biological oxidations—MAOA—bipolar disorder	0.00116	0.0012	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—ADM—bipolar disorder	0.00115	0.0012	CbGpPWpGaD
Betaxolol—CYP1A2—Metapathway biotransformation—COMT—bipolar disorder	0.00115	0.00119	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—ADM—bipolar disorder	0.00113	0.00117	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00112	0.00117	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—TACR1—bipolar disorder	0.00112	0.00116	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—TSHB—bipolar disorder	0.00112	0.00116	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PDE4B—bipolar disorder	0.00112	0.00116	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.00112	0.00116	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKR1C4—bipolar disorder	0.00112	0.00116	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.0011	0.00114	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—TSHB—bipolar disorder	0.0011	0.00114	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PDE4B—bipolar disorder	0.0011	0.00114	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—TACR1—bipolar disorder	0.0011	0.00114	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKR1C4—bipolar disorder	0.00109	0.00113	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—HTR2A—bipolar disorder	0.00107	0.00111	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—HTR2A—bipolar disorder	0.00105	0.00109	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—DGKH—bipolar disorder	0.00103	0.00107	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—HTR1A—bipolar disorder	0.00102	0.00106	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—TAC1—bipolar disorder	0.00101	0.00105	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—DGKH—bipolar disorder	0.00101	0.00104	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—HTR1A—bipolar disorder	0.001	0.00104	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—IMPA2—bipolar disorder	0.000997	0.00104	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—HTR2C—bipolar disorder	0.000988	0.00103	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—DRD1—bipolar disorder	0.000988	0.00103	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—TAC1—bipolar disorder	0.000985	0.00102	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—DRD1—bipolar disorder	0.000966	0.001	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—HTR2C—bipolar disorder	0.000966	0.001	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—DRD3—bipolar disorder	0.000957	0.000993	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—DRD5—bipolar disorder	0.000941	0.000977	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—DRD3—bipolar disorder	0.000936	0.000971	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HTR1A—bipolar disorder	0.000929	0.000964	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—DRD4—bipolar disorder	0.000929	0.000964	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RGS4—bipolar disorder	0.000923	0.000958	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—DRD5—bipolar disorder	0.00092	0.000955	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—TAC1—bipolar disorder	0.000915	0.000949	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—HTR1A—bipolar disorder	0.000909	0.000943	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—DRD4—bipolar disorder	0.000909	0.000943	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RGS4—bipolar disorder	0.000903	0.000937	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HTR2C—bipolar disorder	0.000897	0.000931	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—DRD1—bipolar disorder	0.000897	0.000931	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—TAC1—bipolar disorder	0.000895	0.000929	CbGpPWpGaD
Betaxolol—CYP2D6—Biological oxidations—POMC—bipolar disorder	0.000889	0.000923	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—HTR2C—bipolar disorder	0.000878	0.000911	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—DRD1—bipolar disorder	0.000878	0.000911	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—ADCY2—bipolar disorder	0.000874	0.000907	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—DRD3—bipolar disorder	0.000869	0.000902	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—DRD2—bipolar disorder	0.000865	0.000898	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—POMC—bipolar disorder	0.000856	0.000889	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—ADCY2—bipolar disorder	0.000855	0.000888	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—DRD3—bipolar disorder	0.00085	0.000882	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—DRD2—bipolar disorder	0.000846	0.000879	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—DRD4—bipolar disorder	0.000843	0.000875	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—POMC—bipolar disorder	0.000838	0.00087	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—DRD4—bipolar disorder	0.000825	0.000856	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—IMPA1—bipolar disorder	0.000795	0.000825	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—ADCY2—bipolar disorder	0.000794	0.000824	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—DRD2—bipolar disorder	0.000786	0.000816	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—ADCY2—bipolar disorder	0.000777	0.000806	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—DRD2—bipolar disorder	0.000769	0.000798	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000758	0.000787	CbGpPWpGaD
Betaxolol—CYP1A2—Biological oxidations—POMC—bipolar disorder	0.000754	0.000782	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TRPC3—bipolar disorder	0.000713	0.00074	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TRPC3—bipolar disorder	0.000698	0.000724	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ADM—bipolar disorder	0.00068	0.000706	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NDUFV2—bipolar disorder	0.000676	0.000702	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—IMPA1—bipolar disorder	0.000674	0.000699	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ADM—bipolar disorder	0.000665	0.000691	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TSHB—bipolar disorder	0.000663	0.000688	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TACR1—bipolar disorder	0.000663	0.000688	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PDE4B—bipolar disorder	0.000663	0.000688	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000658	0.000683	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AKR1C4—bipolar disorder	0.000655	0.00068	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TSHB—bipolar disorder	0.000648	0.000673	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PDE4B—bipolar disorder	0.000648	0.000673	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TACR1—bipolar disorder	0.000648	0.000673	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000606	0.000629	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—HTR2A—bipolar disorder	0.000593	0.000615	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NR1D1—bipolar disorder	0.000588	0.000611	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NDUFV2—bipolar disorder	0.000573	0.000595	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NCAN—bipolar disorder	0.000563	0.000584	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AKR1C4—bipolar disorder	0.000555	0.000576	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SLC5A3—bipolar disorder	0.000551	0.000572	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HTR2A—bipolar disorder	0.00055	0.000571	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR1A—bipolar disorder	0.000549	0.00057	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TAC1—bipolar disorder	0.00054	0.000561	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—HTR2A—bipolar disorder	0.000538	0.000559	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR1A—bipolar disorder	0.000537	0.000557	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR2C—bipolar disorder	0.00053	0.00055	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—DRD1—bipolar disorder	0.00053	0.00055	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TAC1—bipolar disorder	0.000529	0.000549	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—DRD1—bipolar disorder	0.000518	0.000538	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR2C—bipolar disorder	0.000518	0.000538	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NTRK2—bipolar disorder	0.000516	0.000535	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—DRD3—bipolar disorder	0.000513	0.000533	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GSK3A—bipolar disorder	0.000511	0.00053	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NTRK2—bipolar disorder	0.000504	0.000523	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—DRD3—bipolar disorder	0.000502	0.000521	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GSK3A—bipolar disorder	0.0005	0.000519	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NR1D1—bipolar disorder	0.000498	0.000517	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—DRD4—bipolar disorder	0.000498	0.000517	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—DRD4—bipolar disorder	0.000487	0.000506	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—POMC—bipolar disorder	0.000484	0.000502	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NCAN—bipolar disorder	0.000477	0.000495	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—POMC—bipolar disorder	0.000473	0.000491	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ADCY2—bipolar disorder	0.000469	0.000487	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TCF7L2—bipolar disorder	0.000467	0.000485	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLC5A3—bipolar disorder	0.000467	0.000485	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—DRD2—bipolar disorder	0.000464	0.000482	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ADCY2—bipolar disorder	0.000459	0.000476	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TCF7L2—bipolar disorder	0.000457	0.000475	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—DRD2—bipolar disorder	0.000454	0.000471	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—POMC—bipolar disorder	0.00044	0.000456	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—POMC—bipolar disorder	0.00043	0.000446	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NTRK1—bipolar disorder	0.00042	0.000436	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NTRK1—bipolar disorder	0.000411	0.000427	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—S100B—bipolar disorder	0.000409	0.000424	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—S100B—bipolar disorder	0.0004	0.000415	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CLOCK—bipolar disorder	0.000399	0.000414	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—TSHB—bipolar disorder	0.000388	0.000403	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CACNB2—bipolar disorder	0.000388	0.000403	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—TPH2—bipolar disorder	0.000388	0.000403	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—DPYD—bipolar disorder	0.000382	0.000397	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NRG1—bipolar disorder	0.000361	0.000374	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CACNA1C—bipolar disorder	0.000355	0.000369	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NRG1—bipolar disorder	0.000353	0.000366	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	0.000346	0.000359	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CLOCK—bipolar disorder	0.000338	0.00035	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—TPH2—bipolar disorder	0.000329	0.000341	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—TSHB—bipolar disorder	0.000329	0.000341	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CACNB2—bipolar disorder	0.000329	0.000341	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR2A—bipolar disorder	0.000325	0.000337	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—DPYD—bipolar disorder	0.000324	0.000336	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR2A—bipolar disorder	0.000318	0.00033	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SNAP25—bipolar disorder	0.00031	0.000322	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CACNA1C—bipolar disorder	0.000301	0.000312	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	0.000293	0.000304	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000289	0.0003	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ADCY2—bipolar disorder	0.000275	0.000285	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SNAP25—bipolar disorder	0.000263	0.000273	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GSK3B—bipolar disorder	0.000262	0.000272	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—POMC—bipolar disorder	0.00026	0.000269	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—INS—bipolar disorder	0.000258	0.000268	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GSK3B—bipolar disorder	0.000256	0.000266	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—POMC—bipolar disorder	0.000254	0.000264	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—INS—bipolar disorder	0.000253	0.000262	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—COMT—bipolar disorder	0.000235	0.000244	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MAOA—bipolar disorder	0.000234	0.000242	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ADCY2—bipolar disorder	0.000233	0.000242	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—COMT—bipolar disorder	0.000199	0.000207	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MAOA—bipolar disorder	0.000198	0.000205	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MTHFR—bipolar disorder	0.00019	0.000197	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MTHFR—bipolar disorder	0.000161	0.000167	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—POMC—bipolar disorder	0.000152	0.000158	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—INS—bipolar disorder	0.000151	0.000157	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—POMC—bipolar disorder	0.000129	0.000134	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—INS—bipolar disorder	0.000128	0.000133	CbGpPWpGaD
